ESR1 and neoplasm: A higher level of IL-2 is associated with damage to regional lymph nodes and low tumor differentiation (Figure 2 and Figure 3), as well as HER2-positive and ER-negative tumor status and a high level of Ki-67 expression (Figure 5 and Figure 6).